Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen E. Zale is active.

Publication


Featured researches published by Stephen E. Zale.


Pharmaceutical Research | 2000

Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability

Henry R. Costantino; Laleh Firouzabadian; Ken Hogeland; Chichih Wu; Chris Beganski; Karen G Carrasquillo; Melissa Córdova; Kai Griebenow; Stephen E. Zale; Mark A. Tracy

AbstractPurpose. To investigate the effect of atomization conditions on particle size and stability of spray-freeze dried protein. Methods. Atomization variables were explored for excipient-free (no zinc added) and zinc-complexed bovine serum albumin (BSA). Particle size was measured by laser diffraction light scattering following sonication in organic solvent containing poly(lactide-co-glycolide) (PLG). Powder surface area was determined from the N2 vapor sorption isotherm. Size-exclusion chromatography (SEC) was used to assess decrease in percent protein monomer. Fourier-transform infrared (FTIR) spectroscopy was employed to estimate protein secondary structure. PLG microspheres were made using a non-aqueous, cryogenic process and release of spray-freeze dried BSA was assessed in vitro. Results. The most significant atomization parameter affecting particle size was the mass flow ratio (mass of atomization N2 relative to that for liquid feed). Particle size was inversely related to specific surface area and the amount of protein aggregates formed. Zinc-complexation reduced the specific surface area and stabilized the protein against aggregation. FTIR data indicated perturbations in secondary structure upon spray-freeze drying for both excipient-free and zinc-complexed protein. Conclusions. Upon sonication, spray-freeze dried protein powders exhibited friability, or susceptibility towards disintegration. For excipient-free protein, conditions where the mass flow ratio was > ∼0.3 yielded sub-micron powders with relatively large specific surface areas. Reduced particle size was also linked to a decrease in the percentage of protein monomer upon drying. This effect was ameliorated by zinc-complexation, via a mechanism involving reduction in specific surface area of the powder rather than stabilization of secondary structure. Reduction of protein particle size was beneficial in reducing the initial release (burst) of the protein encapsulated in PLG microspheres.


Journal of Biomedical Materials Research | 1997

Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis

Yan Zhang; Stephen E. Zale; Laura Sawyer; Howard Bernstein

The effects of encapsulated metal salts on poly(DL-lactide-co-glycolide) (PLGA) water uptake and degradation properties were investigated in this work. Salts of varying aqueous solubility characteristics were incorporated into PLGA films either as particles or by codissolution in polymer solutions. Polymer films were characterized with respect to the kinetics of water uptake, morphology changes, degradation, and weight loss after hydration. It was found that these properties are strongly influenced by the presence and nature of encapsulated salts. Effects range from minor changes in water uptake profile with no significant difference in degradation kinetics to major alterations in water uptake kinetics together with a several-fold decrease in the polymer degradation rate. Possible mechanistic explanations for the observed effects are discussed.


Archive | 1996

Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent

Hye Jung Lee; Olufunmi L. Johnson; Stephen E. Zale; Mark A. Tracy


Science | 1998

Sustained delivery of proteins for novel therapeutic products

Raymond T. Bartus; Mark A. Tracy; Dwaine F. Emerich; Stephen E. Zale


Journal of Pharmaceutical Sciences | 2002

Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability

Henry R. Costantino; Laleh Firouzabadian; Chichih Wu; Karen G. Carrasquillo; Kai Griebenow; Stephen E. Zale; Mark A. Tracy


Archive | 1995

Composition for sustained release of non-aggregated erythropoietin

Stephen E. Zale; Paul A. Burke; Howard Bernstein; Avram Brickner


Archive | 2001

Preparation of injectable suspensions having improved injectability

J. Michael Ramstack; M. Gary I. Riley; Stephen E. Zale; Joyce M. Hotz; Olufunmi L. Johnson


Journal of Pharmaceutical Sciences | 2004

Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres

Henry R. Costantino; Olufunmi Lily Johnson; Stephen E. Zale


Archive | 1997

Device for the sustained release of aggregation-stabilized, biologically active agent

Paul A. Burke; Stephen E. Zale; Mark A. Tracy; Olufunmi L. Johnson; Howard Bernstein; M. Amin Khan; Henry Auer


Archive | 1996

Device for releasing aggregation-stabilized, biologically active agent

Paul A. Burke; Stephen E. Zale; Mark A. Tracy; Olufunmi Lily Johnson; Howard Bernstein; M. Amin Khan; Avram Brickner; Henry Auer

Collaboration


Dive into the Stephen E. Zale's collaboration.

Researchain Logo
Decentralizing Knowledge